Allucent

Allucent, formerly known by other names, is a global provider of comprehensive drug development solutions, operating across a wide spectrum of therapeutic areas. With over 30 years of experience and a presence in more than 60 countries, the company leverages its extensive history to support clients in bringing novel treatments to market. Its services are designed to address the intricate challenges inherent in the drug development lifecycle, from early-stage research to regulatory submission.

The company's core philosophy centers on an individualized partnership approach, delivering experience-driven insights and specialized expertise. This client-centric model aims to guide sponsors through the complexities of clinical trials and drug delivery. To understand the human capital driving these efforts, one can Meet Allucent's team for insights into their leadership and operational structure. Allucent employs between 1,000-5,000 individuals, reflecting a significant operational scale.

Founded in 1994, Allucent generates substantial revenue, reported at $361.6M, and operates within the Management Consulting and Business Services industries. Its product and service offerings encompass critical areas such as clinical research, project team management, drug development strategy, biopharmaceutical support, regulatory affairs, and data management. These services cater to small, mid-size, and biotech sponsors seeking to advance their therapeutic molecules and achieve quality and regulatory milestones.